Idarucizumab

Tax included
Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis.
MedChemExpress 
HY-108739

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Neuroscience-Neuromodulation
CAS
1362509-93-0